BioCentury
ARTICLE | Distillery Therapeutics

Endocrine / Metabolic

July 25, 2017 8:33 PM UTC

In vitro and mouse studies suggest a modified NMU peptide that agonizes NMUR2 could help treat obesity. The agonist consisted of a PEGylated, eight amino acid from the NMU C-terminus containing a napt...

BCIQ Company Profiles

Takeda Pharmaceutical Co. Ltd.

BCIQ Target Profiles

Neuromedin U (NMU)